New distributor Interlux Group to sell suPARnostic® in the Baltic countries

Fri Jan 24 2020

Interlux Group is an international company operating from Vilnius, Lithuania and with a presence in the medical technology market for more than 25 years.

Interlux distributes products from diagnostic companies such as Becton Dickinson, DiaSorin, QIAGEN etc. in all the Baltic states, and has a staff of more than 100 people.

CEO Jakob Knudsen, ViroGates, says in a comment:
”ViroGates is pleased to announce this collaboration with Interlux Group, the leading supplier of diagnostic products in the Baltic region.

We have been very happy with the insights and relations that Interlux have acquired. We have already met with a few hospitals in the Baltic countries and they have been very keen to implement our products, and we believe that this can be facilitated much stronger by ways of an experienced local player such as Interlux.”

CEO of Interlux Group, Dr. Audrius Matuzevicius says:
“We are very happy to have signed an agreement with ViroGates and are looking forward to the cooperation. suPARnostic® will from now on be available for the emergency medicine in the Baltics and we consider suPARnostic® a very good tool for supporting the Triage algorithm at the hospitals.

We recently presented suPAR at the conference of Laboratory medicine in Vilnius, with a very positive feedback from the audience.
Interlux see a very interesting potential in suPAR and are looking forward to implement it at the hospitals in our region”.

+800

published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of 3 products:

Photo of The suPARnostic® Quick Triage kit

Quick Triage

A Point of Care Solution

Photo of suPARnostic® TurbiLatex

TurbiLatex

For Automated Systems

Photo of suPARnostic® ELISA

ELISA Assay

Clinical and Research

suPAR is used in clinical routine in 38 hospitals

38 hospitals use suPAR in clinical routine for triage of patients in the Emergency Departments and COVID-19 units. Clinical routine is defined by the placement of two Purchasing Orders within the last 12 months rolling. This period covers October 1, 2021, until September 30, 2022.
Some hospital locations cannot be disclosed due to confidentiality.

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates